Results 201 to 210 of about 130,724 (273)

Extended susceptibility testing for refractory Helicobacter pylori infection: regional testing should guide antimicrobial decision making. [PDF]

BMC Infect Dis
Paroikaki M, Navalan H, Pallett SJC, Mughal N, Davies F, Alqahtani SA, Moore LSP.   +6 more
europepmc   +1 more source

Computational Validation of Multi‐Epitope mRNA Vaccine Targeting Streptococcus anginosus Surface Protein (TMPC) as an Effective Alternative Treatment to Reduce Gastric Cancer

MicrobiologyOpen, Volume 15, Issue 1, February 2026.
Design process for messenger RNA vaccines. Candidate proteins are initially screened using immunoinformatics, after which selected epitopes are assembled into a multi‐epitope vaccine. The vaccine construct was evaluated through molecular docking, molecular dynamics simulations, and in silico immune simulations, followed by population coverage analysis ...
Fei Zhu, Yuying Luo, Ziyou Zhou, Rongliu Qin, Shiyang Ma, Yizhong Xu, Jie Chen, Pinhua Pan   +7 more
wiley   +1 more source

Helicobacter pylori infection is associated with an increased risk of chronic obstructive pulmonary disease and asthma. [PDF]

Gut Pathog
Chung C, Lee KN, Han K, Shin DW, Lee SW.
europepmc   +1 more source

Natural Products in Cancer Prevention and Therapy: Current Challenges and Future Directions

MedComm, Volume 7, Issue 2, February 2026.
Natural products play a pivotal role in cancer therapy. They induce cancer cell death by reprogramming four metabolic pathways while precisely targeting the tumor microenvironment and immune cells. These compounds not only leverage novel delivery systems for innovative applications but also demonstrate unique therapeutic efficacy across clinical stages:
Ruimiao Qian, Jun Ge, Ni Fan, Zheng Sun, Chengcheng Zhao, Yujiao Sun, Yingpeng Li, Yunfei Li, Hui Fu   +8 more
wiley   +1 more source

Impact of helicobacter pylori infection on the efficacy of ICIs in gastric cancer. [PDF]

BMC Cancer
Huang Y, Hu Y.
europepmc   +1 more source

Inflammation and Cancer: Molecular Mechanisms and Therapeutic Targets

MedComm, Volume 7, Issue 2, February 2026.
Chronic inflammation fuels tumorigenesis via “internal drivers” and “external attractions.” Targeting these core mechanisms with combined therapies/novel deliveries enables precise, potent anti‐inflammatory–antitumor treatment. ABSTRACT Inflammation is a core pathological factor regulating tumor initiation, progression, and therapeutic resistance, and ...
Xiaodie Liu, Ziyuan Wang, Huirong Zhu, Yicun Han, Qing Ji   +4 more
wiley   +1 more source

The Impact of Helicobacter pylori Infection on Retinal Nerve Fiber Layer and Macula. [PDF]

Invest Ophthalmol Vis Sci
Miao H, Qu T, Huang Y, Fan S, Yang Y, Lv A, Hu J, Guo L, Jia Q, Li Z, Zhang S, Li Y, Shi W, Chen Y, Chen S, Yan H.   +15 more
europepmc   +1 more source

Gut Microbial Variations Associated With Proton Pump Inhibitor Use in the Boston Puerto Rican Health Study

Pharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
ABSTRACT Proton pump inhibitors (PPI), used to treat gastrointestinal disorders, are associated with alterations in the gut microbiome. However, this is understudied in Puerto Ricans who have unique lifestyle characteristics. Puerto Ricans, including participants of the Boston‐Puerto Rican Health Study (BPRHS), report high PPI use.
Deepika Dinesh, Xochitl C. Morgan, Hanseul Kim, Tammy M. Scott, Mahdi Garelnabi, Jong Soo Lee, Kelsey M. Mangano, Long H. Nguyen, Curtis Huttenhower, Katherine L. Tucker, Natalia Palacios   +10 more
wiley   +1 more source

Quantifying the effects of the Correa pathway from Helicobacter pylori infection to gastric cancer: causal inference found in 6.8 million Koreans. [PDF]

BMC Cancer
Oh HJ, Kim CH, Park HW, Park B.
europepmc   +1 more source

Seroprevalence of Helicobacter pylori Infection Among Asymptomatic Patients Served by a Safety-Net Healthcare System. [PDF]

Clin Gastroenterol Hepatol
Thrift AP, Dinarvand P, Juarez L, Brown J, Avila D, Zafiro Garcia-Villanueva JM, Danek LC, Mahmood H, Porter T, Gotschall A, Pirzada NF, Rueda JJ, Lu LB, Ali A, Anyakorah I, Bhattarai SJ, Fatima A, Garcia J, Nguyen HV, Joshi B, Juneja M, Lateef MS, Mujtaba N, Nambi PV, Orr JS, Rahman H, Nguyen S, Waqar A, Chen Y, Graham DY, El-Serag HB, Tan MC.   +31 more
europepmc   +1 more source